Mark Fendrick, MD, Discusses Value-Based Insurance Design
Dr. Mark Fendrick, MD, Professor of Medicine and Health Management and Policy, Schools of Medicine and Public Health, University of Michigan, Co-Editor-in-Chief, The American Journal of Managed Care, says that there are levers organizations and stakeholders can pull to achieve the goal of improving quality and value in cancer care. Dr. Fendrick discusses the importance of combining the supply side, or how you pay doctors, and the demand side of value, or consumer engagement. Dr. Fendrick also says that the goal of improved health and cost containment can be achieved when the two sides are combined.
This video was taken on November 16 at AJMC's Translating Evidence-Based Research Into Value-Based Decisions in Oncology.
The House passed a resolution Wednesday authorizing a lawsuit challenging President Barack Obama's constitutional authority to delay the employer mandate in the federal healthcare reform law. The measure was adopted on a 225-201 largely party-line vote.
Len Nichols, PhD, director of the Center for Health Policy Research and Ethics (CHPRE) and a professor of Health Policy at George Mason University, says that transparency in healthcare is an important concept.
While Incyte and Genentech announced partnership to study each of their immunooncology molecules in NSCLC, AstraZeneca and Kyowa Hakko Kirin signed a similar agreement to evaluate their candidate molecules in multiple solid tumors.